Apydan extent 150 mg
Apydan extent 150 mg is a medicine authorised by Swissmedic under authorisation number 57883. The authorisation holder is Desitin Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 November 2010 and the authorisation is valid without a time limit. ATC code N03AF02 places the medicine in the group Antiepileptics.
| Authorisation number | 57883 |
|---|---|
| Name | Apydan extent 150 mg |
| Full name | Apydan extent 150 mg, Tabletten |
| Authorisation holder | Desitin Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AF02 |
| First authorisation | 10 November 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Apydan extent 150 mg, Tabletten | B | 10 November 2010 |
| 2 | Apydan extent 300 mg, Tabletten | B | 10 November 2010 |
| 3 | Apydan extent 600 mg, Tabletten | B | 10 November 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 50 | Tablette(n) | N03AF02 | 01.07.1. | B |
| 8 | 50 | Tablette(n) | N03AF02 | 01.07.1. | B |
| 14 | 50 | Tablette(n) | N03AF02 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Apydan extent 150 mg authorised in Switzerland?
Yes. Apydan extent 150 mg is authorised by Swissmedic under authorisation number 57883, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Apydan extent 150 mg have?
Apydan extent 150 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Apydan extent 150 mg?
The authorisation holder is Desitin Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.